SCNI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Scinai Immunotherapeutics Ltd (SCNI) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The technical indicators are bearish, financial performance is weak, and there are no positive catalysts or trading signals to justify an investment at this time.
The stock is in a bearish trend with MACD negatively expanding below 0, RSI at 14.327 indicating oversold conditions, and moving averages showing a downward trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels (S1: 0.481, S2: 0.432), suggesting further downside potential.
NULL identified. No recent news or significant trading trends to act as a catalyst for upward price movement.
Weak financial performance with declining net income (-4.29% YoY), EPS dropping to 0 (-100% YoY), and a negative gross margin (-202.29). Additionally, the stock has a 60% probability of declining further in the short term (-2.54% in the next day, -7.17% in the next week).
In Q4 2024, revenue remained flat at $206,000 (0.00% YoY growth), net income dropped to -$2,230,000 (-4.29% YoY), and EPS fell to 0 (-100% YoY). Gross margin is negative at -202.29, showing no improvement.
No data available on analyst ratings or price target changes.
